Target intelligence / Profile preview

Oral polymicrobial biofilm

Molecular classification
Other
01

Overview

Oral polymicrobial biofilm refers to a highly organized and structured community of multiple microbial species—including bacteria, fungi, and sometimes archaea or protozoa—adhering to oral surfaces (teeth, mucosa, implants). These communities are embedded in an extracellular polymeric substance (EPS) matrix that provides protection from host immunity and antibiotics. Oral biofilms play a central role in initiating and perpetuating a wide variety of oral diseases, including dental caries, periodontitis, and peri-implant infections, and are characterized by metabolic cooperation, virulence factor production, and immune modulation. Their complex nature and resilience pose significant therapeutic challenges, necessitating innovative strategies beyond conventional antimicrobial use. It is important to note that "Oral polymicrobial biofilm" is not a conventional molecular target or receptor; rather, it describes a collective microbial structure. This entry is therefore not a druggable target in the traditional sense (e.g., receptor, enzyme, ion channel), but instead represents a pathophysiological niche or community. This makes "is_incorrect: true" the appropriate designation for molecular target databases seeking single, defined biomolecules.

Other names
Oral biofilmDental plaqueMultispecies oral biofilmPolymicrobial dental biofilm
02

Mechanism of action

Disruption of cell membranes (e.g., by chlorhexidine, antimicrobial peptides); Inhibition of bacterial protein synthesis (e.g., doxycycline); Inhibition of DNA replication (e.g., ciprofloxacin); Inhibition of cell wall synthesis (e.g., amoxicillin); Reactive oxygen species generation; Extracellular matrix destabilization.

03

Biological functions

Microbial colonizationImmune evasionVirulence promotionMetabolic cooperation
04

Disease associations

InfectionInflammationPeriodontitisPeri-implantitisCaries
05

Safety considerations

Difficult eradication due to biofilm resilienceAntimicrobial resistance/toleranceNon-specific host tissue toxicity (for some antimicrobials)Microbiome disruption
06

Interacting drugs

Chlorhexidine

4 more in the full profile.

07

Biomarkers

Null (no established molecular biomarkers for selection or monitoring; diagnosis is mainly morphological/microbiological)

Beyond the preview

Go deeper on Oral polymicrobial biofilm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral polymicrobial biofilm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call